The effectiveness of oral Cicaglucal on wound healing and pruritus management in patients with Epidermolysis bullosa

Phase 2

Recruiting

• Conditions: Epidermolysis bullosa; Epidermolysis bullosa.

• Registration Number: IRCT20150825023753N22
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Patients with epidermolysis bullosa who have been confirmed by a dermatologist
Consent of the patient and the patient's parents to participate in the study
The patient complains of skin sores and itching

Exclusion Criteria

Positive history of drug hypersensitivity
Patients who have problems with swallowing any type of medication

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The number of wounds on the surface of the patient's body. Timepoint: Before drug administration and one month after drug administration. Method of measurement: Count the number of wounds.;Severity of itching. Timepoint: Before drug administration and one month after drug administration. Method of measurement: Dynamic Pruritus Score (DPS).

Secondary Outcome Measures

Name	Time	Method
Overall improvement rate from the patient's point of view. Timepoint: One month after taking the drug. Method of measurement: Patient global impression of improvement(PGI-I).;Overall improvement rate from the physician's point of view. Timepoint: One month after taking the drug. Method of measurement: Impression of improvement (CGI-I).